Research Papers RSS
Acetyl-L-carnitine is effective in the treatment of early stages of Alzheimer's disease and vascular dementia.
CONCLUSION: Acetyl-L-carnitine (ALC) can be recommended in the abovementioned doses for treatment of early stages of Alzheimer’s disease and Vascular Dementia.
Acetyl-l-carnitine and R-alpha-lipoic acid partially reverses brain decay and RNA/DNA oxidation associated with memory loss in rats.
CONCLUSION: These results suggest that feeding ALCAR and LA to old rats improves performance on memory tasks by lowering oxidative damage and improving mitochondrial function.
Acetyl-l-carnitine delays the mitochondrial decay of aging and improves cognitive function in Alzheimers disease.
CONCLUSION: A recent meta--analysis of 21 double--blind clinical trials of acetyl carnitine in the treatment of mild cognitive impairment and mild Alzheimer's disease showed significant efficacy vs. placebo. A meta--analysis of 4 clinical trials of LA for treatment of neuropathic deficits in diabetes showed significant efficacy vs. placebo.
Acetyl-l-carnitine improves depression in senile patients.
Evaluation of the effects of L-acetylcarnitine on senile patients suffering from depression.
CONCLUSION: “This investigation establishes that LAC is effective in counteracting symptoms of depression in the elderly. Relief of depressive symptomatology is expressed by decreased scores in the Hamilton Rating Scale for Depression and Beck Depression Inventory and by beneficial effects with regard to behavioural aspects”.
Tags
- All
- Acetyl- L-Carnitine
- Alpha-GPC
- Alzheimer's disease
- anticipatory anxiety
- B Vitamins
- cognitive function
- Cognitive Impairment
- depression
- folate
- hepatic encephalopathy.
- Hericium erinaceum
- Homocysteine-Lowering
- hyperhomocysteinemia
- L--theanine
- Lion's Mane mushroom
- occupational stress
- R-alpha-lipoic acid
- RNA/DNA oxidation
- vascular dementia
- vitamin B12
- vitamin B6